Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be Presented at the Pain Therapeutics Summit in Boston MIAMI, FL ...

GenSight Biologics' lead product candidate, GS010, is in Phase III trials in Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible blindness in teens and ...

Two decades ago, when two genetic mutations were discovered in Asia that gave scientists a better idea of how pain sensations ...

In today’s 2024 modern era, many people are experiencing constant foot discomfort and pain. Whether it is because of ...

For residents in North Houston and The Woodlands, relief from foot pain is within reach. Doctor's Inc. offers advanced, ...

From A+ skincare products to cleaning products that are super easy to use, products to help with cooking, and so much more.